Medication-related osteonecrosis of the jaw related to epacadostat and pembrolizumab
Jean‐François Decaux, Michèle Magremanne
Topics & Concepts
PembrolizumabOsteonecrosis of the jawMedicineImmunotherapyIpilimumabImmune systemCancer researchInternal medicineImmunologyBisphosphonateOsteoporosisBone health and treatmentsCancer Diagnosis and TreatmentBone and Joint Diseases